# Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

> **NCT00203580** · PHASE4 · COMPLETED · sponsor: **University of Calgary** · enrollment: 910 (—)

## Conditions studied

- Thrombosis
- Thromboembolism
- Venous Thrombosis

## Interventions

- **DRUG:** Tinzaparin sodium

## Key facts

- **NCT ID:** NCT00203580
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-12
- **Primary completion:** —
- **Final completion:** 2002-03
- **Target enrollment:** 910 (—)
- **Last updated:** 2007-02-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203580, "Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00203580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*